SOLVDDX

Overview

SOLVDDX is developing a functional precision oncology platform designed to begin at diagnosis — preserving viable tumor tissue with non-formalin reagents. Confirmed pathology diagnosis establishes the foundation for live tumor response testing, which is integrated with next-generation sequencing, pharmacogenomics, drug exposure, and clinical evidence to rank treatment options with a Treatment Suitability Score and a separate Evidence Confidence Score. Built as a clinical decision platform rather than a chemosensitivity assay, its initial clinical focus is pancreatic ductal adenocarcinoma (PDAC), with expansion contemplated across additional solid tumors.

Products & services

• Viable tissue collection in non-formalin media
• Live tumor response testing of drugs and clinical regimens
• Integrated pathology, NGS, and pharmacogenomic evidence
• Explainable treatment ranking with suitability and confidence scores